Kilitch Drugs (India) Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
KILITCH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kilitch Drugs (India) Limited has submitted a quarterly compliance certificate under SEBI Regulation 74(5) for the period ended 30th June 2025. The certificate, issued by the company's Registrar and Share Transfer Agent (MUFG Intime India Private Limited, formerly Link Intime), confirms that all securities received from depository participants for dematerialisation during the quarter were properly verified and confirmed to the depositories. The physical share certificates received were mutilated and cancelled as per the standard process, and the names of the depositories have been substituted as the registered owners in the company's records within the prescribed timelines.
This is a routine regulatory compliance filing with no material impact on the business, financials, or stock price. It simply confirms that share dematerialisation activities during the quarter were processed in line with SEBI norms.